Skip to main content
Clinical Trials/JPRN-UMIN000026094
JPRN-UMIN000026094
Completed
未知

Safety and efficacy of transcatheter arterial micro embolization (TAME) using Imipenem / Cilastatin (IPM/CS) for chronic musculoskeletal pain refractory to non-surgical management. - Safety and efficacy of TAME for chronic musculoskeletal pain refractory to non-surgical management.

Tottori university, Faculty of medicine0 sites20 target enrollmentApril 2, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Musculoskeletal chronic pain refractory to non-surgical management(Glenohumeral joint, elbow joint, hip joint and knee joint)
Sponsor
Tottori university, Faculty of medicine
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 2, 2017
End Date
March 31, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tottori university, Faculty of medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Adaptation of treating surgically. 2\)Neoplasm 3\)Severe arteriosclerosis 4\)Pregnant female, female with the possibility of the pregnancy or nursing female 5\)6\)Iodine Allergy 7\)IPM/CS Allergy 8\)Using sodium valproate 9\)Patients with the past of hypersensitivity for carbapenem system, penicillin system or cephem antibiotics. 10\)Severe depression 11\)Uncontrollable severe diabetes mellitus 12\)Patients who have difficulty in going to hospital follow\-up after this treatment enforcement. 13\)Patients who abnormal vessels are not recognized in an angiography.

Outcomes

Primary Outcomes

Not specified

Similar Trials